Stockreport

BriaCell Showcases Robust Anti-Cancer Activity of Personalized Off-the-Shelf Immunotherapy Pipeline at the 2024 SITC Conference [Yahoo! Finance]

BriaCell Therapeutics Corp. - Common Shares  (BCTX) 
PDF Novel therapy activates both innate and adaptive immune systems Proof of concept Phase 1/2 Study of Bria-BRES™ in metastatic breast cancer currently underway Bria-O [Read more]